These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1200066)

  • 21. Migration of spermatozoa in cervical mucus from women using copper intrauterine devices.
    Liedholm P; Sjöberg NO
    Acta Obstet Gynecol Scand; 1974; 53(4):375-6. PubMed ID: 4440466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of modified intrauterine device (IUD) TCu 380 with chromium filaments in the immediate postpartum].
    Hernández Valencia M; Becerril Flores LC
    Ginecol Obstet Mex; 2000 Feb; 68():70-6. PubMed ID: 10774108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intrauterine contraceptive devices. Mode of action, experiences, complications (author's transl)].
    Ludwig H
    Geburtshilfe Frauenheilkd; 1976 Feb; 36(2):97-108. PubMed ID: 943359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights on the mode of action of intrauterine contraceptive devices in women.
    Alvarez F; Brache V; Fernandez E; Guerrero B; Guiloff E; Hess R; Salvatierra AM; Zacharias S
    Fertil Steril; 1988 May; 49(5):768-73. PubMed ID: 3360166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intrauterine contraception].
    Lambotte R
    Rev Med Liege; 1984 Apr; 39(7):257-60. PubMed ID: 6729292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of non-medicated and copper IUDs on sperm migration.
    Aref I; Kandil O; El-tagi A; Morad MR
    Contracept Deliv Syst; 1983 Jul; 4(3):203-6. PubMed ID: 12265363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation in vivo and in vitro of cervical mucus in IUD users: differences between women wearing copper and progesterone releasing IUDs.
    Scarselli G; Noci I; Chelo E; Tantini C; Livi C
    Acta Eur Fertil; 1983; 14(4):279-82. PubMed ID: 6689512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Actinomycosis infection associated with intrauterine contraceptive devices.
    Keebler C; Chatwani A; Schwartz R
    Am J Obstet Gynecol; 1983 Mar; 145(5):596-9. PubMed ID: 6829637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone-releasing silicone-rubber intrauterine contraceptive devices. Effect of incorporation of various compounds on intrauterine contraceptive devices in rats.
    Doyle LL
    Am J Obstet Gynecol; 1975 Feb; 121(3):405-11. PubMed ID: 1115155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further observations on the influence of the intrauterine device on ovum and sperm distribution in the monkey.
    Mastroianni L; Suzuki S; Manabe Y; Watson F
    Am J Obstet Gynecol; 1967 Nov; 99(5):649-61. PubMed ID: 4963753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose concentration of cervical mucus in Copper T IUD users.
    Kandil O; Hassanein M; Zaki K; Rizk GA
    Contracept Deliv Syst; 1983 Jul; 4(3):195-201. PubMed ID: 12265362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [IUD mode of action].
    Andrade AT
    Bol Cent Biol Reprod; 1987; 5():9-18. PubMed ID: 12281402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrauterine contraceptive device use and pelvic inflammatory disease.
    Kaufman DW; Shapiro S; Rosenberg L; Monson RR; Miettinen OS; Stolley PD; Slone D
    Am J Obstet Gynecol; 1980 Jan; 136(2):159-62. PubMed ID: 7352496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative study on the clinical effects and endometrial findings of IUD].
    Chao CK
    Toho Igakkai Zasshi; 1988 Mar; 34(6):550-60. PubMed ID: 12343145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statement on intrauterine devices (IUDs).
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1987 Dec; 21(6):3-5. PubMed ID: 12268853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New studies link IUDs, infertility; say copper devices safer.
    Contracept Technol Update; 1985 Jun; 6(6):81-3. PubMed ID: 12313655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical study of a progesterone-releasing intrauterine contraceptive device.
    Brenner PF; Cooper DL; Mishell DR
    Am J Obstet Gynecol; 1975 Mar; 121(5):704-6. PubMed ID: 1115173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.